Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest GlaxoSmithKline Stories

2014-01-28 16:25:09

Off-label marketing fraud cases have involved systematic manipulation of the regulatory scheme governing pharma products and treatment of patients by doctors SAN FRANCISCO, Jan. 28, 2014 /PRNewswire-iReach/ -- In recent media reports, 2013 is being called the Year of the Whistleblower - driven by a certain American taking sanctuary in Russia. However, 2013 was important in the whistleblower world for reasons unrelated to Mr. Snowden: it marked the tenth year of government recovery in...

2014-01-10 08:23:28

HOERSHOLM, Denmark and SAN DIEGO, Jan. 10, 2014 /PRNewswire/ -- Santaris Pharma A/S has announced today that they have signed an agreement with GlaxoSmithKline (GSK), whereby, pursuant to an option right, GSK gains access to Santaris' Locked Nucleic Acid (LNA) technology to develop RNA-targeted medicines. Under the terms of the agreement, GSK can obtain rights to utilize Santaris Pharma's proprietary Locked Nucleic Acid (LNA) Drug Platform to research, develop and commercialize...

2014-01-09 08:29:06

The alli® Brand Encourages a Healthy, Balanced Diet with Community Support, Recipes from Chef Richard Blais and Expert Tips for Success PARSIPPANY, N.J., Jan. 9, 2014 /PRNewswire/ -- GlaxoSmithKline Consumer Healthcare today announced the launch of the 60-Day Kickstart - a new campaign on Facebook that offers free support for striking a healthy, balanced diet in the new year. The program, created courtesy of the alli® brand- the only FDA-approved over the counter weight loss aid -offers...

2014-01-08 16:23:54

LONDON, Jan. 8, 2014 /PRNewswire/ -- MWW (www.mww.com), one of the top five independent public relations firms in the United States, today announced the appointment of Simon Gentry to lead a new public affairs practice. Focused on providing clients with public affairs support in London and Brussels, Simon will draw on his extensive experience in the financial services, healthcare, technology, energy and nutrition sectors to expand MWW's offering in London. He has worked for a wide...

2014-01-06 08:26:49

GlaxoSmithKline Consumer Healthcare and Walgreens Encourage Smokers to Use Social Media to Share Their Reasons for Quitting Smoking PARSIPPANY, N.J., Jan. 6, 2014 /PRNewswire/ -- GlaxoSmithKline (GSK) Consumer Healthcare and Walgreens have teamed up to launch Sponsorship to Quit, a free online quit-smoking program through Walgreens that smokers can personalize with customized tools and tips during their journey to quit. After completing an online consultation, a smoker can access...

2013-12-27 23:04:33

“Should I take drugs for my herpes or not?” That is a recent topic on Positivesingles.com. Los Angeles (PRWEB) December 27, 2013 In December PositiveSingles.com hold a survey for members regarding whether or not they have taken their prescribed drugs since being diagnosed with herpes. 83.61% of members express that they typically take their prescribed drugs once being diagnosed with herpes. The medicines they usually take are valtrex 500 milligrams, lysin vitamins or garlic...

2013-12-23 08:27:14

The Brazilian Government is Heavily Investing in the Local Manufacturing of ARVs, Hindering Market Entry of New Drugs, According to a New Report from Decision Resources BURLINGTON, Mass., Dec. 23, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Brazil's National Health System (SUS) currently provides coverage for 22 drugs that are distributed free of charge to more than 300,000...

2013-12-18 08:29:11

Generic Erosion of Market Leaders Will Be Offset by the First Once-Daily LABA/ICS Combination and Emerging Anticytokine Agents, According to Findings from Decision Resources BURLINGTON, Mass., Dec. 18, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the drug market for asthma will remain relatively flat through 2022. Currently, the market is driven by maintenance therapies that...

GSK Stops Paying Docs To Market Meds
2013-12-18 09:15:55

Rebekah Eliason for redOrbit.com – Your Universe Online Amid accusations of bribery and scandal, GlaxoSmithKline (GSK), one of the leading drug makers, will stop paying doctors to promote its drugs and cease targets for number of prescriptions filled for the marketing staff. This is a first for the giant drug company, which has long been fighting scandals over its sales practices. Such a huge step is a major challenge to other drug companies and could force them to follow their example....

2013-12-11 08:32:05

David Zezza named Board Chairman SAN FRANCISCO, Dec. 11, 2013 /PRNewswire/ -- Drip Drop Inc., makers of the first oral rehydration solution (ORS) to combine medical standards of rehydration therapy and excellent taste, made two important additions to its Board of Directors this month: Stan Lech, President of PharmaMax, has joined the board, and David Zezza, a Managing Partner for Pacific Advantage Capital (PAC), and one of Drip Drop's earliest and most active investors, was...